{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:20:34Z","timestamp":1792081234840,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR051394"],"award-info":[{"award-number":["AR051394"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.clim.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T12:36:59Z","timestamp":1527338219000},"page":"119-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis"],"prefix":"10.1016","volume":"195","author":[{"given":"Nithya","family":"Lingampalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sokolove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren J.","family":"Lahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess D.","family":"Edison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Michael","family":"Holers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Deane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clim.2018.05.004_bb0005","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3899\/jrheum.160522","article-title":"Quantifying disease in challenging conditions: incidence and prevalence of rheumatoid arthritis","volume":"43","author":"Scublinsky","year":"2016","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2018.05.004_bb0010","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/ard.2010.133371","article-title":"Group as: nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden","volume":"70","author":"Neovius","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"6937","key":"10.1016\/j.clim.2018.05.004_bb0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.clim.2018.05.004_bb0020","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.clim.2018.05.004_bb0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/annrheumdis-2012-203130","article-title":"What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review","volume":"73","author":"van Nies","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.clim.2018.05.004_bb0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.39603","article-title":"Preclinical rheumatoid arthritis: progress toward prevention","volume":"68","author":"Mankia","year":"2016","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.clim.2018.05.004_bb0035","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/art.11224","article-title":"Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?","volume":"48","author":"Majka","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.clim.2018.05.004_bb0040","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.2007.076679","article-title":"Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis","volume":"67","author":"Majka","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.clim.2018.05.004_bb0045","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.27638","article-title":"The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner","volume":"62","author":"Deane","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.clim.2018.05.004_bb0050","first-page":"1282","article-title":"Rheumatoid factors antedating clinical rheumatoid arthritis","volume":"18","author":"Aho","year":"1991","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.clim.2018.05.004_bb0055","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/art.1780311004","article-title":"The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study","volume":"31","author":"del Puente","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.clim.2018.05.004_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/ard.59.2.149","article-title":"A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor","volume":"59","author":"Halldorsdottir","year":"2000","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.clim.2018.05.004_bb0065","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780350810","article-title":"Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease","volume":"35","author":"Kurki","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.clim.2018.05.004_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/rheumatology\/31.6.365","article-title":"Incidence of rheumatoid arthritis in a genetically predisposed population","volume":"31","author":"Silman","year":"1992","journal-title":"Br. J. Rheumatol."},{"issue":"8","key":"10.1016\/j.clim.2018.05.004_bb0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/ard.45.8.684","article-title":"Rheumatoid factor tests in the diagnosis and prediction of rheumatoid arthritis","volume":"45","author":"Walker","year":"1986","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2018.05.004_bb0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.clim.2018.05.004_bb0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","article-title":"Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis","volume":"62","author":"Kokkonen","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.05.004_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13075-016-0940-2","article-title":"Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis","volume":"18","author":"Brink","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.clim.2018.05.004_bb0095","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2018.05.004_bb0100","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar3237","article-title":"Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis","volume":"13","author":"Kokkonen","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.clim.2018.05.004_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/jimmunol\/195.1.8","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. 1998","volume":"195","author":"Schellekens","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2018.05.004_bb0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.clim.2018.05.004_bb0115","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.62.9.870","article-title":"Clinical utility of the anti-CCP assay in patients with rheumatic diseases","volume":"62","author":"Lee","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.clim.2018.05.004_bb0120","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/art.38017","article-title":"Performance of anti-cyclic citrullinated peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease","volume":"65","author":"Demoruelle","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2018.05.004_bb0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.2010.131102","article-title":"Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities","volume":"70","author":"Ioan-Facsinay","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.clim.2018.05.004_bb0130","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.clim.2018.05.004_bb0135","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clim.2018.05.004_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1196\/annals.1313.031","article-title":"Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis","volume":"1050","author":"Greiner","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.clim.2018.05.004_bb0145","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s10067-007-0601-6","article-title":"Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF","volume":"26","author":"Silveira","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"5 Suppl 31","key":"10.1016\/j.clim.2018.05.004_bb0150","first-page":"S59","article-title":"Autoantibodies in early arthritis: advances in diagnosis and prognostication","volume":"21","author":"Hueber","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7","key":"10.1016\/j.clim.2018.05.004_bb0155","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2009.122739","article-title":"Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis","volume":"69","author":"Miriovsky","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.clim.2018.05.004_bb0160","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/art.38307","article-title":"Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis","volume":"66","author":"Sokolove","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.clim.2018.05.004_bb0165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kev347","article-title":"Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment","volume":"55","author":"Gerlag","year":"2016","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.clim.2018.05.004_bb0170","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.1997.03540350075038","article-title":"Recommendations guiding physicians in biomedical research involving human subjects","volume":"277","author":"World Medical Association declaration of Helsinki","year":"1997","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clim.2018.05.004_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.05.004_bb0180","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2741\/e379","article-title":"Development and deployment of antigen arrays for investigation of B-cell fine specificity in autoimmune disease","volume":"4","author":"Sokolove","year":"2012","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.clim.2018.05.004_bb0185","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/ar2706","article-title":"Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis","volume":"11","author":"Hueber","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.clim.2018.05.004_bb0190","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/ard.2006.054924","article-title":"Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines","volume":"66","author":"Hueber","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.clim.2018.05.004_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clim.2018.05.004_bb0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/acr.21778","article-title":"Prospective study of posttraumatic stress disorder and disease activity outcomes in US veterans with rheumatoid arthritis","volume":"65","author":"Mikuls","year":"2013","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2018.05.004_bb0205","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"5116","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"vol. 98","author":"Tusher","year":"2001"},{"issue":"9","key":"10.1016\/j.clim.2018.05.004_bb0210","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","article-title":"Open source clustering software","volume":"20","author":"de Hoon","year":"2004","journal-title":"Bioinformatics"},{"issue":"17","key":"10.1016\/j.clim.2018.05.004_bb0215","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1093\/bioinformatics\/bth349","article-title":"Java Treeview--extensible visualization of microarray data","volume":"20","author":"Saldanha","year":"2004","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.clim.2018.05.004_bb0220","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.30213","article-title":"Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor","volume":"63","author":"Todd","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.clim.2018.05.004_bb0225","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/annrheumdis-2013-204543","article-title":"IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies","volume":"74","author":"Laurent","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.clim.2018.05.004_bb0230","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.4049\/jimmunol.1402334","article-title":"IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies","volume":"194","author":"Anquetil","year":"2015","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2018.05.004_bb0235","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/art.509","article-title":"Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618302468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618302468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:57:51Z","timestamp":1761494271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618302468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":47,"alternative-id":["S1521661618302468"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.05.004","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}